Research Paper Volume 16, Issue 8 pp 7188—7216
Integrative analysis based on the cell cycle-related genes identifies TPX2 as a novel prognostic biomarker associated with tumor immunity in breast cancer
Figure 8. (A) Correlation analysis between TPX2 expression and representative immune checkpoints from TCGA database. (B) The relationship between TPX2 expression and immune microenvironment. *P < 0.05, **P < 0.01, ***P < 0.001.